• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 16, 2023

    3/16/23 6:59:03 AM ET
    $SYPR
    $TG
    $TITN
    $TLS
    Industrial Machinery/Components
    Industrials
    Metal Fabrications
    Industrials
    Get the next $SYPR alert in real time by email

    Companies Reporting Before The Bell

    • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.

    • ImmunoPrecise Antibodies (NASDAQ:IPA) is projected to report quarterly loss at $0.17 per share on revenue of $3.96 million.

    • Blue Apron Hldgs (NYSE:APRN) is expected to report quarterly loss at $0.83 per share on revenue of $100.13 million.

    • Yiren Digital (NYSE:YRD) is estimated to report earnings for its second quarter.

    • KE Holdings (NYSE:BEKE) is likely to report quarterly earnings at $0.08 per share on revenue of $2.29 billion.

    • Hello Gr (NASDAQ:MOMO) is projected to report quarterly earnings at $0.29 per share on revenue of $465.30 million.

    • Children's Place (NASDAQ:PLCE) is likely to report quarterly loss at $4.09 per share on revenue of $455.33 million.

    • Sidus Space (NASDAQ:SIDU) is projected to report quarterly loss at $0.15 per share on revenue of $1.25 million.

    • WiSA Technologies (NASDAQ:WISA) is expected to report quarterly loss at $17.50 per share on revenue of $1.00 million.

    • Pyxis Tankers (NASDAQ:PXS) is estimated to report quarterly earnings at $0.46 per share on revenue of $16.06 million.

    • VEON (NASDAQ:VEON) is estimated to report earnings for its fourth quarter.

    • REE Automotive (NASDAQ:REE) is estimated to report quarterly loss at $0.11 per share on revenue of $950 thousand.

    • Sypris Solutions (NASDAQ:SYPR) is projected to report earnings for its fourth quarter.

    • Global X Guru Index ETF (NYSE:GURU) is projected to report quarterly loss at $0.10 per share on revenue of $6.01 million.

    • Tredegar (NYSE:TG) is projected to report earnings for its fourth quarter.

    • Titan Machinery (NASDAQ:TITN) is likely to report quarterly earnings at $1.13 per share on revenue of $684.35 million.

    • PureCycle Technologies (NASDAQ:PCT) is projected to report earnings for its fourth quarter.

    • Xunlei (NASDAQ:XNET) is estimated to report earnings for its fourth quarter.

    • Tsakos Energy Navigation (NYSE:TNP) is likely to report quarterly earnings at $3.10 per share on revenue of $225.00 million.

    • Academy Sports (NASDAQ:ASO) is likely to report quarterly earnings at $1.84 per share on revenue of $1.80 billion.

    • G-III Apparel Group (NASDAQ:GIII) is projected to report quarterly earnings at $0.45 per share on revenue of $770.72 million.

    • Provention Bio (NASDAQ:PRVB) is expected to report quarterly loss at $0.46 per share on revenue of $8.30 million.

    • Signet Jewelers (NYSE:SIG) is projected to report quarterly earnings at $5.38 per share on revenue of $2.65 billion.

    • Dollar Gen (NYSE:DG) is estimated to report quarterly earnings at $2.96 per share on revenue of $10.24 billion.

    • Designer Brands (NYSE:DBI) is estimated to report quarterly loss at $0.02 per share on revenue of $791.81 million.

    • Honest Co (NASDAQ:HNST) is projected to report quarterly loss at $0.05 per share on revenue of $80.37 million.

    • Williams-Sonoma (NYSE:WSM) is estimated to report quarterly earnings at $5.45 per share on revenue of $2.60 billion.

    • LENSAR (NASDAQ:LNSR) is likely to report quarterly loss at $0.25 per share on revenue of $10.00 million.

    • UroGen Pharma (NASDAQ:URGN) is likely to report quarterly loss at $1.07 per share on revenue of $18.51 million.

    • Iterum Therapeutics (NASDAQ:ITRM) is projected to report earnings for its fourth quarter.

    • Evelo Biosciences (NASDAQ:EVLO) is likely to report earnings for its fourth quarter.

    • Liquidia (NASDAQ:LQDA) is estimated to report quarterly loss at $0.15 per share on revenue of $3.55 million.

    • Telos (NASDAQ:TLS) is estimated to report earnings for its fourth quarter.

    • Paratek Pharmaceuticals (NASDAQ:PRTK) is likely to report quarterly earnings at $0.09 per share on revenue of $63.45 million.

    • AC Immune (NASDAQ:ACIU) is estimated to report quarterly loss at $0.26 per share on revenue of $1.71 million.

    • BK Technologies (AMEX:BKTI) is estimated to report quarterly earnings at $0.05 per share on revenue of $18.15 million.

    • Acurx Pharmaceuticals (NASDAQ:ACXP) is expected to report earnings for its fourth quarter.

    • Janus Intl Gr (NYSE:JBI) is likely to report quarterly earnings at $0.22 per share on revenue of $260.79 million.

    • Lizhi (NASDAQ:LIZI) is projected to report earnings for its fourth quarter.

    • Coda Octopus Group (NASDAQ:CODA) is projected to report quarterly earnings at $0.09 per share on revenue of $5.59 million.

    • Lands' End (NASDAQ:LE) is likely to report quarterly earnings at $0.06 per share on revenue of $518.45 million.

    • Acacia Research (NASDAQ:ACTG) is expected to report earnings for its fourth quarter.

    • American Strategic (NYSE:NYC) is expected to report earnings for its fourth quarter.

    • MediWound (NASDAQ:MDWD) is likely to report quarterly loss at $0.59 per share on revenue of $6.60 million.

    • Real Brokerage (NASDAQ:REAX) is likely to report quarterly loss at $0.03 per share on revenue of $88.15 million.

    • Jabil (NYSE:JBL) is projected to report quarterly earnings at $1.85 per share on revenue of $8.09 billion.

    • Prestige Consumer (NYSE:PBH) is expected to report quarterly earnings at $1.28 per share on revenue of $1.54 billion.

    • RumbleON (NASDAQ:RMBL) is likely to report quarterly loss at $0.14 per share on revenue of $398.55 million.

    • Destination XL Group (NASDAQ:DXLG) is estimated to report quarterly earnings at $0.10 per share on revenue of $144.44 million.

    • Apyx Medical (NASDAQ:APYX) is estimated to report quarterly loss at $0.14 per share on revenue of $12.94 million.

    • CENTRAL & EASTERN EUROPE (NYSE:CEE) is estimated to report earnings for its Fiscal Year 2022.

    • Aveanna Healthcare Hldgs (NASDAQ:AVAH) is expected to report quarterly loss at $0.02 per share on revenue of $448.16 million.

    • CION Invt (NYSE:CION) is projected to report quarterly earnings at $0.35 per share on revenue of $49.39 million.

    • Despegar.com (NYSE:DESP) is projected to report quarterly loss at $0.08 per share on revenue of $150.25 million.

    Companies Reporting After The Bell

    • Clipper Realty (NYSE:CLPR) is expected to report earnings for its fourth quarter.

    • Vitru (NASDAQ:VTRU) is estimated to report quarterly loss at $0.08 per share on revenue of $81.31 million.

    • Groupon (NASDAQ:GRPN) is expected to report quarterly loss at $0.40 per share on revenue of $161.55 million.

    • Akumin (NASDAQ:AKU) is expected to report earnings for its fourth quarter.

    • Karat Packaging (NASDAQ:KRT) is estimated to report quarterly earnings at $0.32 per share on revenue of $96.12 million.

    • HEXO (NASDAQ:HEXO) is estimated to report quarterly loss at $0.16 per share on revenue of $26.31 million.

    • Impac Mortgage Holdings (AMEX:IMH) is expected to report earnings for its fourth quarter.

    • Adamis Pharmaceuticals (NASDAQ:ADMP) is estimated to report earnings for its fourth quarter.

    • ATI Physical Therapy (NYSE:ATIP) is likely to report quarterly loss at $0.07 per share on revenue of $162.66 million.

    • Hallador Energy (NASDAQ:HNRG) is estimated to report earnings for its fourth quarter.

    • TOMI Environmental Solns (NASDAQ:TOMZ) is likely to report earnings for its fourth quarter.

    • Comstock (AMEX:LODE) is estimated to report quarterly loss at $0.05 per share on revenue of $40 thousand.

    • EzFill Holdings (NASDAQ:EZFL) is likely to report earnings for its fourth quarter.

    • Blend Labs (NYSE:BLND) is projected to report quarterly loss at $0.16 per share on revenue of $44.98 million.

    • Purple Innovation (NASDAQ:PRPL) is expected to report quarterly loss at $0.06 per share on revenue of $144.16 million.

    • HeartBeam (NASDAQ:BEAT) is projected to report earnings for its fourth quarter.

    • Arena Group Holdings (AMEX:AREN) is projected to report quarterly loss at $0.76 per share on revenue of $62.29 million.

    • Onconova Therapeutics (NASDAQ:ONTX) is projected to report quarterly loss at $0.28 per share on revenue of $60 thousand.

    • Geron (NASDAQ:GERN) is estimated to report quarterly loss at $0.12 per share on revenue of $120 thousand.

    • Trevi Therapeutics (NASDAQ:TRVI) is expected to report earnings for its fourth quarter.

    • CymaBay Therapeutics (NASDAQ:CBAY) is expected to report earnings for its fourth quarter.

    • Acutus Medical (NASDAQ:AFIB) is projected to report quarterly loss at $0.71 per share on revenue of $4.32 million.

    • BioLife Solns (NASDAQ:BLFS) is likely to report quarterly loss at $0.17 per share on revenue of $43.41 million.

    • Eastman Kodak (NYSE:KODK) is projected to report earnings for its fourth quarter.

    • Co-Diagnostics (NASDAQ:CODX) is likely to report quarterly loss at $0.15 per share on revenue of $5.50 million.

    • SenesTech (NASDAQ:SNES) is likely to report earnings for its fourth quarter.

    • Panbela Therapeutics (NASDAQ:PBLA) is estimated to report earnings for its fourth quarter.

    • Eton Pharmaceuticals (NASDAQ:ETON) is projected to report quarterly earnings at $0.01 per share on revenue of $9.12 million.

    • Sarcos Technology (NASDAQ:STRC) is expected to report quarterly loss at $0.15 per share on revenue of $5.70 million.

    • Netcapital (NASDAQ:NCPL) is estimated to report earnings for its third quarter.

    • HireQuest (NASDAQ:HQI) is estimated to report quarterly earnings at $0.28 per share on revenue of $8.80 million.

    • RiceBran Tech (NASDAQ:RIBT) is expected to report earnings for its fourth quarter.

    • Montauk Renewables (NASDAQ:MNTK) is estimated to report quarterly earnings at $0.09 per share on revenue of $57.32 million.

    • System1 (NYSE:SST) is expected to report quarterly loss at $0.37 per share on revenue of $185.46 million.

    • Achieve Life Sciences (NASDAQ:ACHV) is projected to report quarterly loss at $0.83 per share on revenue of $100 thousand.

    • PLBY Group (NASDAQ:PLBY) is projected to report quarterly loss at $0.17 per share on revenue of $75.56 million.

    • Microvast Holdings (NASDAQ:MVST) is projected to report quarterly loss at $0.15 per share on revenue of $60.50 million.

    • Traeger (NYSE:COOK) is projected to report quarterly loss at $0.15 per share on revenue of $118.31 million.

    • GoHealth (NASDAQ:GOCO) is estimated to report quarterly earnings at $1.33 per share on revenue of $358.04 million.

    • FedEx (NYSE:FDX) is estimated to report quarterly earnings at $2.73 per share on revenue of $22.76 billion.

    • WM Tech (NASDAQ:MAPS) is expected to report quarterly loss at $0.13 per share on revenue of $47.83 million.

    • Leafly Holdings (NASDAQ:LFLY) is projected to report quarterly loss at $0.18 per share on revenue of $12.12 million.

    • Meta Materials (NASDAQ:MMAT) is projected to report earnings for its fourth quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $SYPR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYPR
    $TG
    $TITN
    $TLS

    CompanyDatePrice TargetRatingAnalyst
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    FedEx Corporation
    $FDX
    2/3/2026$380.00Equal Weight → Overweight
    Wells Fargo
    FedEx Corporation
    $FDX
    2/3/2026$427.00Mkt Perform → Outperform
    Bernstein
    FedEx Corporation
    $FDX
    1/21/2026$271.00Buy → Neutral
    Rothschild & Co Redburn
    The Honest Company Inc.
    $HNST
    1/16/2026Overweight → Underweight
    Analyst
    FedEx Corporation
    $FDX
    1/13/2026$280.00Outperform → Neutral
    BNP Paribas Exane
    FedEx Corporation
    $FDX
    1/9/2026$365.00Neutral → Buy
    BofA Securities
    Dollar General Corporation
    $DG
    1/8/2026$170.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $SYPR
    $TG
    $TITN
    $TLS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $94,524 worth of shares (48,138 units at $1.96) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/3/26 5:27:37 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Schorsch Nicholas S bought $19,269 worth of shares (1,664 units at $11.58) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    2/2/26 9:31:35 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    $SYPR
    $TG
    $TITN
    $TLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Honest Company to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    LOS ANGELES, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care products company dedicated to creating products for everyone—from babies to adults—that raise the standards of clean and bring joy to every moment, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company will host a conference call and webcast to review these results at 1:45pm PT/4:45pm ET on the same day. For those interested in participating in the conference call by phone, please click here. Following registration, dial-in details will be provided via email. To avoid delays, we encourage par

    2/11/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Blend Named a 2026 HousingWire Tech100 Mortgage Award Winner for Seventh Consecutive Year

    Technology recognition underscores Blend's continued leadership in mortgage technology transformation and commitment to meaningful innovation. Blend (NYSE:BLND), a leading digital origination platform for banks, credit unions, and mortgage lenders, today announced that it has been named a 2026 HousingWire Tech100 Mortgage award winner. Blend's seventh year of recognition highlights the company's ongoing commitment to advancing mortgage technology and delivering measurable impact for financial institutions nationwide. The HousingWire Tech100 Mortgage awards recognize the most innovative technology companies serving the U.S. mortgage industry. Winners are selected based on their technolog

    2/11/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    WILLIAMS-SONOMA, INC. PARTNERS WITH OPENAI TO TEST ADS IN CHATGPT

    Williams-Sonoma, Inc. (NYSE:WSM), the world's largest digital-first, design-led, and sustainable home furnishings retailer, announced today participation in the OpenAI Ad Pilot Program, becoming one of the first companies to test ads in ChatGPT. As an early participant, Williams-Sonoma, Inc. will explore how advertising in ChatGPT can reach customers at decision-making moments, helping surface relevant, high-quality products while preserving the trusted and transparent user experience both companies value. "AI is rapidly enhancing product discovery and becoming an integral part of how consumers make informed purchasing decisions," said Williams-Sonoma, Inc. President and CEO, Laura Alber.

    2/11/26 9:00:00 AM ET
    $WSM
    Home Furnishings
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXOBRID issued to MEDIWOUND, LTD

    Submission status for MEDIWOUND, LTD's drug NEXOBRID (SUPPL-10) with active ingredient ANACAULASE-BCDB has changed to 'Approval' on 08/15/2024. Application Category: BLA, Application Number: 761192, Application Classification:

    8/16/24 4:36:54 AM ET
    $MDWD
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for LIVDELZI issued to CYMABAY THERAPEUTICS INC

    Submission status for CYMABAY THERAPEUTICS INC's drug LIVDELZI (ORIG-1) with active ingredient SELADELPAR has changed to 'Approval' on 08/14/2024. Application Category: NDA, Application Number: 217899, Application Classification: Type 1 - New Molecular Entity

    8/14/24 12:53:53 PM ET
    $CBAY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KE Holdings downgraded by Goldman with a new price target

    Goldman downgraded KE Holdings from Buy to Neutral and set a new price target of $19.00

    2/3/26 6:53:05 AM ET
    $BEKE
    Real Estate
    Finance

    FedEx upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded FedEx from Equal Weight to Overweight and set a new price target of $380.00

    2/3/26 6:49:32 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    FedEx upgraded by Bernstein with a new price target

    Bernstein upgraded FedEx from Mkt Perform to Outperform and set a new price target of $427.00

    2/3/26 6:49:22 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    SEC Filings

    View All

    SEC Form 424B3 filed by Acurx Pharmaceuticals Inc.

    424B3 - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)

    2/11/26 4:21:38 PM ET
    $ACXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by The Real Brokerage Inc.

    6-K - Real Brokerage Inc (0001862461) (Filer)

    2/11/26 9:59:12 AM ET
    $REAX
    Real Estate
    Finance

    Designer Brands Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Designer Brands Inc. (0001319947) (Filer)

    2/11/26 6:45:12 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Smith Jason Drew converted options into 15,500 units of Ordinary Shares and sold $147,262 worth of Ordinary Shares (7,479 units at $19.69), increasing direct ownership by 11% to 55,588 units (SEC Form 4)

    4 - UroGen Pharma Ltd. (0001668243) (Issuer)

    2/11/26 2:54:58 PM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Director Riedel Norbert G exercised 30,000 in-the-money shares at a strike of $4.42, increasing direct ownership by 600% to 35,000 units (SEC Form 4)

    4 - Eton Pharmaceuticals, Inc. (0001710340) (Issuer)

    2/5/26 5:18:48 PM ET
    $ETON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SYPR
    $TG
    $TITN
    $TLS
    Leadership Updates

    Live Leadership Updates

    View All

    Designer Brands Inc. Appoints Sheamus Toal as Chief Financial Officer

    Appointment Effective February 16, 2026 COLUMBUS, Ohio, Feb. 11, 2026 /PRNewswire/ -- Designer Brands Inc. (NYSE:DBI) (the "Company," "we," "us," "our," and "Designer Brands"), today announced that Sheamus Toal will join the company as Executive Vice President, Chief Financial Officer and Principal Financial Officer, effective February 16, 2026. Mark Haley, who has served as Interim Principal Financial Officer during the transition period, will return full time to his position as Senior Vice President, Controller and Principal Accounting Officer. Sheamus brings deep financial

    2/11/26 6:45:00 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    Tredegar Appoints David Parks to Board of Directors

    Tredegar Corporation (NYSE:TG) today announced that it has appointed David Parks as an independent director to its Board of Directors. "David's combination of extensive engineering experience, global commercial leadership, and strategic insight makes him an outstanding addition to the Board," said Greg Pratt, Chairman of the Board. Mr. Pratt added, "His steady, inclusive leadership style and broad experience across advanced materials, consumer products and healthcare will help strengthen Tredegar's long-term value for shareholders." About David Parks David Parks brings more than 35 years of global operating, commercial, and strategic leadership experience across healthcare, consumer p

    2/9/26 4:05:00 PM ET
    $TG
    Metal Fabrications
    Industrials

    $SYPR
    $TG
    $TITN
    $TLS
    Financials

    Live finance-specific insights

    View All

    The Honest Company to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    LOS ANGELES, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care products company dedicated to creating products for everyone—from babies to adults—that raise the standards of clean and bring joy to every moment, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company will host a conference call and webcast to review these results at 1:45pm PT/4:45pm ET on the same day. For those interested in participating in the conference call by phone, please click here. Following registration, dial-in details will be provided via email. To avoid delays, we encourage par

    2/11/26 4:05:00 PM ET
    $HNST
    Catalog/Specialty Distribution
    Consumer Discretionary

    Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    FOSTER CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that it will release its fourth quarter and full year 2025 financial results and business highlights before the market opens on Wednesday, February 25, 2026 via press release, which will be available on the Investors and Media section of the Company's website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time. A live and archived audio webcast of the conference call will be available from the Investors and Media section of the Company's website at www.geron.c

    2/11/26 7:27:26 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    InPost, Advent, FedEx, A&R and PPF Announce Agreement on Recommended All-Cash Offer for All Issued and Outstanding InPost Shares at an Offer Price of EUR 15.60 Per Share

    This is a joint press release by InPost S.A. ("InPost" or the "Company") and Iris Lux Bidco S.à r.l. (the "Offeror"). This joint press release is issued pursuant to the provisions of Section 17, paragraph 1 of the European Market Abuse Regulation (596/2014), as well as the provisions of Section 4, paragraphs 1 and 3, Section 5, paragraph 1 and Section 7, paragraph 4 of the Dutch Decree on public takeover bids (Besluit openbare biedingen Wft) (the "Decree") in connection with the intended recommended public offer by the Offeror for all the issued and outstanding shares in the capital of the Company (the "Offer" together with the transactions contemplated in connection therewith the "Transact

    2/9/26 2:59:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care